TARSUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.5 USD | +1.34% |
|
+3.08% | +90.12% |
| 09/05 | Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating | MT |
| 08/05 | Transcript : Tarsus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 39.22 | 39.22 | 49.62 |
| Spread/Res. | -1.84% | -1.84% | -22.41% |
| Spread/Supp. | +10.82% | +56.38% | +68.64% |
| Support | 34.74 | 24.62 | 22.83 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- TARS Stock
- Charts Tarsus Pharmaceuticals, Inc.